The Biomarker Consortium

The Biomarker Consortium is a collaborative public-private initiative that advances medical research by developing and validating biological markers—measurable indicators of health or disease. It brings together government agencies, academia, and industry to share resources and expertise, aiming to improve diagnosis, treatment, and prevention of diseases. By streamlining the discovery process, the consortium helps accelerate the development of new medical tools and personalized approaches to healthcare, ultimately benefiting patients through earlier detection and more effective therapies.